Design and Characterization of Maltoheptaose-<i>b</i>-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen
Tamoxifen citrate (TMC), a non-steroidal antiestrogen drug used for the treatment of breast cancer, was loaded in a block copolymer of maltoheptaose-<i>b</i>-polystyrene (MH-<i>b</i>-PS) nanoparticles, a potential drug delivery system to optimize oral chemotherapy. The nanopa...
Guardado en:
Autores principales: | Marcos Antonio Villetti, Adryana Rocha Clementino, Ilaria Dotti, Patricia Regina Ebani, Eride Quarta, Francesca Buttini, Fabio Sonvico, Annalisa Bianchera, Redouane Borsali |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a6d6ee2b69a846b0bd87357dab1c2a3a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of Tamoxifen and Clomiphene on Ovulation and Pregnancy Rates in Polycystic Ovary Syndrome Patients
por: S Esmaeilzadeh,, et al.
Publicado: (2009) -
Centchroman versus Tamoxifen in the management of mastalgia: a randomized controlled clinical trial
por: S Khadka, et al.
Publicado: (2016) -
ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen
por: Giovanna Pepe, et al.
Publicado: (2021) -
Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy
por: Adehin A, et al.
Publicado: (2020) -
Dose-dependent effects of Hedyotis diffusa extract on the pharmacokinetics of tamoxifen, 4-hydroxytamoxifen, and N-desmethyltamoxifen
por: Yung-Yi Cheng, et al.
Publicado: (2022)